Paper17547827
Adherence-resistance relationships to combination HIV antiretroviral therapy.
Bangsberg DR and 2 others. Curr HIV/AIDS Rep, 2007. Cited by 137 papers, by iCite.
Cite this record
ConductScience Library. Adherence-resistance relationships to combination HIV antiretroviral therapy. Papers, record 17547827. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547827
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Retroviral Agents | Major topic |
| Drug Resistance, Viral | Major topic |
| HIV Infections | Major topic |
| Patient Compliance | Major topic |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Humans | |
| Pharmacogenetics | |
| Protease Inhibitors |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 MH054907 | NIMH NIH HHS | United States | R01MH054907 | PubMed and NIH | NIH RePORTER |
| AA 015287 | NIAAA NIH HHS | United States | K24AA015287 | PubMed and NIH | NIH RePORTER |
| GM 61390 | NIGMS NIH HHS | United States | U01GM061390 | PubMed and NIH | NIH RePORTER |
| MH 54907 | NIMH NIH HHS | United States | R01MH054907 | PubMed and NIH | NIH RePORTER |
| U19GM061390 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00608569 | Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults | Background |
Source ClinicalTrials.gov
References80
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15750116 | Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/15750116 | PubMed |
| 2 | 15668854 | Efavirenz intoxication due to slow hepatic metabolism. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/15668854 | PubMed |
| 3 | 15115831 | Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15115831 | PubMed |
| 4 | 16267764 | Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study. | J Infect Dis | 2005 | https://conductscience.org/library/papers/16267764 | PubMed |
| 5 | 16249701 | Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). | J Acquir Immune Defic Syndr | 2005 | https://conductscience.org/library/papers/16249701 | PubMed |
| 6 | 11437654 | Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants. | Virology | 2001 | https://conductscience.org/library/papers/11437654 | PubMed |
| 7 | 11752705 | In vitro analysis of human immunodeficiency virus type 1 resistance to nevirapine and fitness determination of resistant variants. | J Gen Virol | 2002 | https://conductscience.org/library/papers/11752705 | PubMed |
| 8 | 11502341 | Preventing antiretroviral anarchy in sub-Saharan Africa. | Lancet | 2001 | https://conductscience.org/library/papers/11502341 | PubMed |
| 9 | 15127346 | Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/15127346 | PubMed |
| 10 | 10570031 | Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. | Drug Metab Dispos | 1999 | https://conductscience.org/library/papers/10570031 | PubMed |
| 11 | 14702153 | Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine. | J Infect Dis | 2004 | https://conductscience.org/library/papers/14702153 | PubMed |
| 12 | 16249703 | Selective drug taking during combination antiretroviral therapy in an unselected clinic population. | J Acquir Immune Defic Syndr | 2005 | https://conductscience.org/library/papers/16249703 | PubMed |
| 13 | 16355337 | Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. | Clin Infect Dis | 2006 | https://conductscience.org/library/papers/16355337 | PubMed |
| 14 | 16511415 | Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. | AIDS | 2006 | https://conductscience.org/library/papers/16511415 | PubMed |
| 15 | 14693536 | Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/14693536 | PubMed |
| 16 | 14694092 | Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants. | J Virol | 2004 | https://conductscience.org/library/papers/14694092 | PubMed |
| 17 | 15486844 | Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. | Clin Infect Dis | 2004 | https://conductscience.org/library/papers/15486844 | PubMed |
| 18 | 17457090 | Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. | AIDS | 2007 | https://conductscience.org/library/papers/17457090 | PubMed |
| 19 | 16946457 | Update of the drug resistance mutations in HIV-1: Fall 2006. | Top HIV Med | 2006 | https://conductscience.org/library/papers/16946457 | PubMed |
| 20 | 15622315 | Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. | AIDS | 2004 | https://conductscience.org/library/papers/15622315 | PubMed |
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41847579 | Critical level of food insecurity and nonadherence to antiretroviral therapy among adults living with HIV. | Public Health Action | 2026 | https://conductscience.org/library/papers/41847579 | PubMed |
| 40544855 | Predictors of treatment-emergent resistance to dolutegravir. | Lancet HIV | 2025 | https://conductscience.org/library/papers/40544855 | PubMed |
| 38905197 | LSTM-driven drug design using SELFIES for target-focused de novo generation of HIV-1 protease inhibitor candidates for AIDS treatment. | PLoS One | 2024 | https://conductscience.org/library/papers/38905197 | PubMed |
| 38796507 | Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/38796507 | PubMed |
| 38140667 | A Comprehensive Literature Review of Treatment-Emergent Integrase Resistance with Dolutegravir-Based Regimens in Real-World Settings. | Viruses | 2023 | https://conductscience.org/library/papers/38140667 | PubMed |
| 36350211 | The risk of drug resistance during long-acting antimicrobial therapy. | Proc Biol Sci | 2022 | https://conductscience.org/library/papers/36350211 | PubMed |
| 35797374 | Factors associated with the risk of upper respiratory tract bacterial infections among HIV-positive patients. | PLoS One | 2022 | https://conductscience.org/library/papers/35797374 | PubMed |
| 35444410 | Adherence to HIV Antiretroviral Therapy Among Pregnant and Breastfeeding Women, Non-Pregnant Women, and Men in Burkina Faso: Nationwide Analysis 2019-2020. | Patient Prefer Adherence | 2022 | https://conductscience.org/library/papers/35444410 | PubMed |
| 35213648 | Qualitative systems mapping for complex public health problems: A practical guide. | PLoS One | 2022 | https://conductscience.org/library/papers/35213648 | PubMed |
| 34905404 | Substance Use-Related Intentional Nonadherence to Antiretroviral Therapy Among Young Adults Living with HIV. | AIDS Patient Care STDS | 2022 | https://conductscience.org/library/papers/34905404 | PubMed |
| 34567064 | Using Molecular Transmission Networks to Reveal the Epidemic of Pretreatment HIV-1 Drug Resistance in Guangxi, China. | Front Genet | 2021 | https://conductscience.org/library/papers/34567064 | PubMed |
| 34473060 | Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity. | Elife | 2021 | https://conductscience.org/library/papers/34473060 | PubMed |
| 33451356 | Validation of multiplex PCR sequencing assay of SIV. | Virol J | 2021 | https://conductscience.org/library/papers/33451356 | PubMed |
| 33226999 | Time to treatment disruption in children with HIV-1 randomized to initial antiretroviral therapy with protease inhibitors versus non-nucleoside reverse transcriptase inhibitors. | PLoS One | 2020 | https://conductscience.org/library/papers/33226999 | PubMed |
| 33105694 | Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules. | Molecules | 2020 | https://conductscience.org/library/papers/33105694 | PubMed |
| 32324724 | Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020. | MMWR Recomm Rep | 2020 | https://conductscience.org/library/papers/32324724 | PubMed |
| 32286041 | Target-Based Design of Promysalin Analogues Identifies a New Putative Binding Cleft in Succinate Dehydrogenase. | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/32286041 | PubMed |
| 32011966 | The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic. | J Manag Care Spec Pharm | 2020 | https://conductscience.org/library/papers/32011966 | PubMed |
| 31488063 | Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study. | BMC Infect Dis | 2019 | https://conductscience.org/library/papers/31488063 | PubMed |
| 30668713 | Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy. | J Antimicrob Chemother | 2019 | https://conductscience.org/library/papers/30668713 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17547827
GET https://conductscience.org/api/papers/v1/17547827/references?page=2